Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 9 of 24, showing 10 Applications out of 238 total, starting on record 81, ending on 90

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

81.

ECCT/21/06/05   VAT00008
    A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of ageand older   
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
KEMRI-CCR-PHRD THIKA PROJECT
 
02-08-2021 View

82.

ECCT/21/05/05   The “EMPATHY” Trial
    A randomized, double-blind, placebo-controlled, multicenter study of ensovibep (MP0420) in ambulatory adult patients with symptomatic COVID-19.       
Principal Investigator(s)
1. DR LUCAS OTIENO TINA
2. Dr. Bernhards Ragama Ogutu
3. Dr Deborah Chepngeno Langat
4. Dr Videlis Nduba Nduba
5. Dr Janet Oyieko
Site(s) in Kenya
1. Victoria Biomedical Research Institute (VIBRI) (Kisumu county)
2. Kenyatta University Teaching Referral and Research Hospital (KUTRRH) (Nairobi City county)
3. Kenya Medical Research Institute/US Army Medical Research Directorate-Kenya-Kericho (Kericho county)
4. KEMRI, Centre for Respiratory Diseases Research (CRDR) (Nairobi City county)
5. KEMRI-USAMRD-A, Kisumu Field Station (Kisumu county)
 
11-08-2021 View

83.

ECCT/21/06/10   VAT00008
    A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of age and older   
Principal Investigator(s)
1. Kishorchandra Narsinh Mandaliya
Site(s) in Kenya
1. Kenya Medical Research Institute (Kisumu county)
2. KEMRI/Walter Reed Project Research Center (Kericho county)
3. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county)
4. KEMRI CMR (Kisumu county)
5. Kenya Medical Research Institute (Nairobi City county)
6. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
7. Moi University Clinical Research Centre (Uasin Gishu county)
8. Aga Khan University Hospital (Nairobi City county)
9. KEMRI CCR-Butere County Hospital Site (Kakamega county)
10. Ganjoni Clinic (Mombasa county)
 
16-08-2021 View

84.

ECCT/21/06/07   VAT00008
    A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of age and older   
Principal Investigator(s)
1. Samuel Ouma Gurrion Ouma
Site(s) in Kenya
1. Kenya Medical Research Institute Kisumu Clinical Research Site (Kisumu county)
2. KEMRI/Walter Reed Project Research Center (Kericho county)
3. Ganjoni Clinic (Mombasa county)
4. KEMRI/CCR Partners in Health R&D (PHRD (Nairobi City county)
5. Kenya Medical Research Institute (Nairobi City county)
6. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
7. Moi University Clinical Research Centre (Uasin Gishu county)
8. Aga Khan University Hospital (Nairobi City county)
9. KEMRI CCR-Butere County Hospital Site (Kakamega county)
 
16-08-2021 View

85.

ECCT/21/06/12   VAT00008
    A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the   efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted Recombinant Protein   Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of age   and older   
Principal Investigator(s)
1. Abraham Siika
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
2. KEMRI/Walter Reed Project Research Center (Kericho county)
3. Kenya Medical Research Institute (Kisumu county)
4. Ganjoni Clinic (Mombasa county)
5. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county)
6. Kenya Medical Research Institute (Nairobi City county)
7. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
8. Aga Khan University Hospital (Nairobi City county)
9. KEMRI CCR-Butere County Hospital Site (Bung\'oma county)
 
16-08-2021 View

86.

ECCT/21/06/06   VAT00008
    A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted  Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of ageand older   
Principal Investigator(s)
1. Janet Oyieko
Site(s) in Kenya
1. KEMRI CCR-Butere County Hospital Site (Kakamega county)
2. Kenya Medical Research Institute (Kisumu county)
3. KEMRI/Walter Reed Project Research Center (Kericho county)
4. Ganjoni Clinic (Mombasa county)
5. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county)
6. Kenya Medical Research Institute (Nairobi City county)
7. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
8. Moi University Clinical Research Centre (Uasin Gishu county)
9. Aga Khan University Hospital (Nairobi City county)
10. Kenya Medical Research Institute (Kisumu county)
11. KEMRI/Walter Reed Project Research Center (Kericho county)
12. Ganjoni Clinic (Mombasa county)
13. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county)
14. Kenya Medical Research Institute (Nairobi City county)
15. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
16. Moi University Clinical Research Centre (Uasin Gishu county)
17. Aga Khan University Hospital (Nairobi City county)
18. Kenya Medical Research Institute (Kisumu county)
19. KEMRI/Walter Reed Project Research Center (Kericho county)
20. Ganjoni Clinic (Mombasa county)
21. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county)
22. Kenya Medical Research Institute (Nairobi City county)
23. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
24. Moi University Clinical Research Centre (Uasin Gishu county)
25. Aga Khan University Hospital (Nairobi City county)
26. Kenya Medical Research Institute (Kisumu county)
27. KEMRI/Walter Reed Project Research Center (Kericho county)
28. Ganjoni Clinic (Mombasa county)
29. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county)
30. Kenya Medical Research Institute (Nairobi City county)
31. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
32. Moi University Clinical Research Centre (Uasin Gishu county)
33. Aga Khan University Hospital (Nairobi City county)
34. Kenya Medical Research Institute (Kisumu county)
35. KEMRI/Walter Reed Project Research Center (Kericho county)
36. Ganjoni Clinic (Mombasa county)
37. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county)
38. Kenya Medical Research Institute (Nairobi City county)
39. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
40. Moi University Clinical Research Centre (Uasin Gishu county)
41. Aga Khan University Hospital (Nairobi City county)
 
16-08-2021 View

87.

ECCT/21/06/08   VAT00008
    A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted   Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of ageand older   
Principal Investigator(s)
1. Saleh Mansoor
Site(s) in Kenya
1. Aga Kahn University Nairobi (Nairobi City county)
2. Kenya Medical Research Institute (Kisumu county)
3. KEMRI/Walter Reed Project Research Center (Kericho county)
4. Ganjoni Clinic (Mombasa county)
5. KEMRI/CCR Partners in Health R&D (PHRD (Kiambu county)
6. KEMRI/CCR Partners in Health R&D (PHRD (Kiambu county)
7. Kenya Medical Research Institute (Nairobi City county)
8. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
9. Moi University Clinical Research Centre (Uasin Gishu county)
10. KEMRI CCR-Butere County Hospital Site (Kakamega county)
 
16-08-2021 View

88.

ECCT/21/09/04   Recombinant COVID-19 Vaccine
    A global multicenter, randomized, double-blind, placebo-controlled, phase III clinical trial to evaluate the efficacy, safety, and immunogenicity of recombinant COVID-19 vaccine (Sf9 cells) for the prevention of COVID-19 in adults aged 18 years and older            
Principal Investigator(s)
1. Sylvester Kimaiyo
Site(s) in Kenya
1. KAVI-Institute of Clinical Research (Nairobi City county)
2. Moi Teaching and Referral Hospital (Uasin Gishu county)
3. Kenya Medical Research Institute, Kilifi (Kilifi county)
 
17-09-2021 View

89.

ECCT/21/06/01   ACTIV-2/A5401
    ACTIV-2/A5401 "Adaptive Platform Treatment Trial for Outpatients with COVID-19" (Adapt Out COVID)_   
Principal Investigator(s)
1. Charles Meja Kwobah
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
2. KEMRI Walter Reed Project (Kericho county)
 
01-11-2021 View

90.

ECCT/21/07/03   GBT_131 Inclacumab-Ps 3 Trial.
    A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Safety and Efficacy of Inclacumab in Participants with Sickle Cell Disease Experiencing Vaso-occlusive Crises   
Principal Investigator(s)
1. Prof Jessie N Githanga
2. Fredrick Sirwa Chite
3. Bernhards Ragama Ogutu
4. Videlis N Nduba
Site(s) in Kenya
1. International Cancer Institute (ICI)-Eldorate (Uasin Gishu county)
2. KEMRI/CRDR (Nairobi City county)
3. KEMRI Siaya Clinical Research Annex (Siaya county)
4. Gertrude’s Children’s Hospital. (Nairobi City county)
5. Strathmore University Medical Centre (Nairobi City county)
 
08-11-2021 View